Community Pharmacy Accreditation Renewal Now Open - READ MORE  
close skinny banner

Administering substances by injection and inhalation for treatment purposes authorized as of July 1, 2023

Posted:May 16th, 2023
Read Time: < 1 Min Read

As of July 1, 2023, approved regulatory amendments to O. Reg 202/94 (General) of the Pharmacy Act, 1991 will authorize Ontario’s Part A pharmacists, registered pharmacy students and interns to administer substances listed in the regulations by injection and inhalation for purposes other than patient demonstration and education.

This expansion of scope will enable pharmacy professionals with injection training to better support their patients with the routine injection or inhalation of medications. This will benefit patients being treated for conditions including osteoporosis, diabetes, or rheumatoid arthritis who may have difficulties with self-injection or who fear needles, or those who may require inhaled medications for conditions such as asthma.

The College will be sharing further information and resources prior to the July 1, 2023 implementation through its e-Connect newsletter and on the website.